Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04469127
Title A Phase I/II Multicenter, Open-Label Study of Lu-177-avB3-IAC, for the Treatment of Angiogenic Breast Cancer Patients. (Heroine01)
Acronym Heroine01
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Advanced Imaging Projects, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
Postgraduate Institute of Medical and Research Chandigarh 160 012 India Details
CM Johannesburg Academic Hospital, University of the Witwatersrand Johannesburg 2193 South Africa Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field